1 |
Treatment of infective endophthalmitis by intravitreal drugsKwok, Kwan-ho, Alvin. January 2006 (has links)
Thesis (Ph. D.)--University of Hong Kong, 2006. / Title proper from title frame. Also available in printed format.
|
2 |
Use of novel optoelectronic techniques in the study of ocular deliveryKek, Wee Kuan January 2004 (has links)
No description available.
|
3 |
Treatment of infective endophthalmitis by intravitreal drugsKwok, Kwan-ho, Alvin., 郭坤豪. January 2006 (has links)
published_or_final_version / abstract / Medicine / Doctoral / Doctor of Philosophy
|
4 |
In vitro and in vivo studies of biocompatibility of intraocular tamponade agents /Lui, Wing-chi. January 2009 (has links)
Thesis (M. Phil.)--University of Hong Kong, 2010. / Includes bibliographical references (leaves 116-130). Also available online.
|
5 |
In vitro and in vivo studies of biocompatibility of intraocular tamponade agentsLui, Wing-chi. January 2009 (has links)
Thesis (M. Phil.)--University of Hong Kong, 2010. / Includes bibliographical references (leaves 116-130). Also available in print.
|
6 |
Reducing the complications associated with emulsification in the use of polydimethylsiloxane (PDMS) based silicone oil in vitreous surgery by engineering approachesChan, Yau-kei, 陳佑祺 January 2013 (has links)
Silicone oil (SO) is widely used as the long-term intraocular tamponade in treating various eye diseases such as complicated retinal detachment, proliferative vitreoretinopathy, proliferative diabetic retinopathy, giant retinal tear and ocular trauma. However, its propensity to emulsify is an inherent problem of its long-term use in-vivo. Dispersal of SO into many tiny oil droplets causes numerous complications such as inflammation, glaucoma and reproliferation. It may also be responsible for possible toxicity to both retina and optic nerve.
Emulsification is one of the problems associated to the use of SO as a long-term intraocular tamponade. This study focused on the understanding on the physical nature and formation of in-vivo SO emulsion and the development of methods to reduce the complications associated with emulsification of SO by engineering approaches. A stepper motor driven mechanical platform was built to study the fluid flow of SO within an eye model chamber during eye-like movements and a quantitative method was established to study SO emulsification, both in-vivo and in-vitro. This method was used to compare the relative resistance of different SO against emulsification. In the last part of the thesis a novel rinse was proposed which aimed at removing the emulsified SO droplets in-vivo in an effective way.
In the dynamic eye model experiment, both the increase in shear viscosity of SO and the extent of SO fill had an effect in reducing the shear. These effects were small compared to the effect of indents at reducing shear rate during eye-like movements.
When SO emulsions from patients were analyzed it was found that over 90% of the emulsified droplets were outside the observable range under slit-lamp biomicroscopy.
When the emulsification resistance of SO was tested using the quantitative method the result confirmed that SO with high-molecular-weight component (HMWC) was more emulsification resistant than SO with the same shear viscosity. The addition of HMWC increases the elasticity and thus increasing its resistance against emulsification.
A novel rinse was also proposed to remove the emulsified droplets using physical phenomenon of double emulsification.
To conclude, this study improved the understanding of the formation of SO emulsification. The clinical observable emulsified droplets are probably in all cases that was just the tip of the iceberg. Three practical suggestions were made: Firstly, the use of SO and encircling scleral buckling procedure in combination might reduce the shear rate. Secondly, the use of HMWC can reduce emulsification. Lastly, there may be a role in rinsing out the emulsified droplets using the proposed novel solution. The novel solution is going to fully developed and commercialized in the near future. / published_or_final_version / Ophthalmology / Doctoral / Doctor of Philosophy
|
7 |
Opthalmic Use Of Sodium Cephalothin: An In Vivo ComparisonCarney, Gerald R. 08 1900 (has links)
A rabbit keratoconjunctivities model was used to evaluate ophthalmic formulations containing 1 percent sodium cephalothin in silicon oil, a 1 percent sodium cephalothin aqueous solution, and a 0.3 percent gentamicin sulfate solution. Rabit eyes were inoculated intracorneally with Pseudomonas aeruginosa, Staphylococcus aureus, or Streptococcus pneumoniae, After topical treatment, none of the antibiotic formulations were effective in the P. aeruginosa model; all three showed good activity against S. aureus, and against S. pneumoniae, the caphalothin formulations were more effective than gentamicin.In a related stability study, the cephalothin potency of the silicon formulation was maintained for 16 weeks at 4, 25, and 450 C These studies suggest that sodium cephalothin can be formulated as an effective and stable ophthalmic dosage form.
|
8 |
In vitro and in vivo studies of biocompatibility of intraocular tamponade agentsLui, Wing-chi., 呂穎芝. January 2009 (has links)
published_or_final_version / Anatomy / Master / Master of Philosophy
|
9 |
Biopolymer-based ocular drug delivery systemsLiu, Weipeng. January 2008 (has links)
Thesis (PH. D.)--Michigan State University. Chemical Engineering, 2008. / Title from PDF t.p. (viewed on Sept. 6, 2009) Includes bibliographical references (p. 116-119). Also issued in print.
|
10 |
In vivo and ex vivo studies of intraocular tamponade agents and their clinical relevance in intraocular drug deliveryMa, Da, 马达 January 2010 (has links)
published_or_final_version / Anatomy / Master / Master of Philosophy
|
Page generated in 0.0543 seconds